院外启动低温治疗对ST段抬高型心肌梗死患者心肌挽救的影响:一项随机试验
该随机对照开放标签终点盲法试验在101例STEMI患者中评估院外启动低温治疗对心肌挽救指数的影响,低温组47例、对照组54例,低温组81%达到目标温度,但心肌挽救指数两组无显著差异(0.37 vs 0.43,p=0.27),且低温干预导致再灌注延迟14分钟。结论提示院外低温作为直接PCI辅助治疗未改善STEMI患者心肌挽救。
要点
- 院外启动低温治疗未改善STEMI患者的心肌挽救指数(0.37 vs 0.43,p=0.27)。
- 低温组81%(38/47)达到目标温度≤35°C,但干预导致再灌注延迟14分钟。
- 心脏生物标志物及临床结局两组无差异,6个月CMR随访亦无显著差异。
核心结论
- 院外诱导的治疗性低温作为直接PCI的辅助治疗未改善STEMI患者的心肌挽救。
研究设计与样本
- 随机、对照、开放标签、终点盲法试验,101例STEMI患者纳入意向性治疗分析(对照组54例,低温组47例)。
- 低温在症状发作6小时内由急救医疗服务启动,使用体表冷却垫和冷盐水,并在导管室继续血管内冷却(再灌注时目标温度≤35°C)。
- 主要比较事件后第4±2天通过心脏磁共振(CMR)测量的心肌挽救指数。
主要发现
- 低温组38/47例(81%)达到目标温度。
- 研究相关干预导致首次医疗接触至再灌注时间延迟14分钟(对照组89±24分钟;低温组103±21分钟;p<0.01)。
- 心肌挽救指数对照组为0.37(±0.26),低温组为0.43(±0.27),p=0.27。
- 心脏生物标志物或临床结局未见差异。
- 初次事件后6个月CMR随访未检测到显著差异。
临床怎么用
- 对于STEMI患者,院外启动低温治疗作为直接PCI辅助策略未显示可改善心肌挽救,且导致再灌注延迟,不支持常规临床应用。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE: To evaluate the effect of prereperfusion hypothermia initiated in the out-of-hospital setting in awake patients with ST-segment elevation myocardial infarction (STEMI) on myocardial salvage measured by cardiac MRI (CMR). METHODS: Hypothermia was initiated within 6 hours of symptom onset by the emergency medical service with surface cooling pads and cold saline, and continued in the cath lab with endovascular cooling (target temperature: ≤35°C at time of reperfusion). Myocardial salvage index (using CMR) was compared in a randomised, controlled, open-label, endpoint blinded trial to a not-cooled group of patients at day 4±2 after the event. RESULTS: After postrandomisation exclusion of 19 patients a total of 101 patients were included in the intention-to-treat analysis (control group: n=54; hypothermia group: n=47). Target temperature was reached in 38/47 patients (81%) in the intervention group. Study-related interventions resulted in a delay in time from first medical contact to reperfusion of 14 min (control group 89±24 min; hypothermia group 103±21 min; p<0.01). Myocardial salvage index was 0.37 (±0.26) in the control group and 0.43 (±0.27) in the hypothermia group (p=0.27). No differences in cardiac biomarkers or clinical outcomes were found. In a CMR follow-up 6 months after the initial event no significant differences were detected. CONCLUSION: Out-of-hospital induced therapeutic hypothermia as an adjunct to primary percutaneous coronary intervention did not improve myocardial salvage in patients with STEMI. TRIAL REGISTRATION NUMBER: NCT01777750.
引用
- Testori C, Beitzke D, Mangold A, et al. Out-of-hospital initiation of hypothermia in ST-segment elevation myocardial infarction: a randomised trial. Heart. 2018. PMID: 30361270. doi:10.1136/heartjnl-2018-313705
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。